Intelligence Platform
Patents
Browse 18 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12396963
Cannabidiol-type cannabinoid compound
granted patentUS 12383512
Cannabidiol-type cannabinoid compound
granted patentUS 12364670
Cannabidiol-type cannabinoid compound
granted patentUS 12357586
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epilepti
granted patentUS 12263139
Use of cannabidiol in the treatment of tuberous sclerosis complex
granted patentUS 12226373
Treatment of fragile X syndrome with cannabidiol
granted patentUS 12213951
Treatment of autism with cannabidiol
granted patentUS 12186282
Treatment of 22Q11.2 deletion syndrome with cannabidiol
granted patentUS 12102619
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
granted patentUS 11826428
Solid solution compositions comprising cannabidiols
granted patentUS 11712474
Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibi
granted patentUS 11364202
Solid forms of cannabidiol and uses thereof
granted patentUS 11285184
Cannabidiol alkaline composition
granted patentUS 10870632
Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cann
granted patentUS 10722581
Phonophoretic cannabidiol composition and transdermal delivery system
granted patentUS 10604467
Solid forms of cannabidiol and uses thereof
granted patentUS 10398776
Phonophoretic cannabidiol composition and transdermal delivery system
granted patentUS 8895078
Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabi
granted